Finance

Beta
Lists
BIOA:NASDAQ
BIOAGE Labs Inc
$25.10
+3.46%
(+0.84) 1D
$25.59
+1.95% (+0.49)
After hours
Closed: Jul 2, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BIOA...
Open
$24.43
High
$25.14
Low
$24.11
Mkt. cap
1.12B
Avg. vol.
606.34K
Volume
418.67K
52-wk high
$25.80
52-wk low
$4.11
EPS
-$2.40
Shares outstanding
44.45M
No. of employees
61
Open
$24.43
High
$25.14
Low
$24.11
Mkt. cap
1.12B
Avg. vol.
606.34K
Volume
418.67K
52-wk high
$25.80
52-wk low
$4.11
EPS
-$2.40
Shares outstanding
44.45M
No. of employees
61
News stories
From sources across the web
About BIOAGE Labs Inc
CEO-
Employees61
Founded2015
HeadquartersEmeryville, California, United States
SectorPharmaceutical industry
Websitebioagelabs.com
Analyst ratings
Based on 5 analysts giving stock ratings to BIOA in the past 3 months
Buy
Buy
3
Hold
2
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for BIOA in the last 3 months.
Highest
Current $25.10
$50.00 (+99.20%)
Average
$37.25 (+48.41%)
Lowest
$23.00 (-8.37%)
Analyst
Recommendation
Action
Price target
Projected
Date
Adam Walsh
Roth MKM
Buy
Reiterated
$36.00
+43.4%
06/17/2026
Michael Ulz
Morgan Stanley
Hold
Maintained
$23.00
-8.4%
06/16/2026
Thomas Shrader
BTIG
Buy
Initiated
$40.00
+59.4%
05/13/2026
Andy Hsieh
William Blair
Hold
Reiterated
-
-
05/11/2026
Joseph Stringer
Needham
Buy
Maintained
$50.00
+99.2%
05/11/2026
Roger Song
Jefferies
Buy
Maintained
$62.00
+147%
03/26/2026
Samantha Semenkow
Citi
Buy
Maintained
$52.00
+107.2%
03/10/2026
Jay Olson
Oppenheimer
Buy
Initiated
$60.00
+139%
02/25/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$73.00
+190.8%
02/13/2026
Last report
May 8, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.52 / -$0.63
+17.13%beat
Revenue / Est. (USD)
2.77M / 1.08M
+155.88%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.41M
2.05M
3.08M
2.77M
Cost of goods sold
19.84M
18.51M
24.50M
20.41M
Cost of revenue
19.84M
18.51M
24.50M
20.41M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.34M
6.68M
7.00M
7.74M
Operating expense
7.34M
6.68M
7.00M
7.74M
Total operating expenses
27.18M
25.19M
31.50M
28.15M
Operating income
-24.77M
-23.14M
-28.42M
-25.38M
Other non operating income
-11.00K
-42.00K
-220.00K
-107.00K
EBT including unusual items
-21.56M
-20.17M
-25.94M
-22.25M
EBT excluding unusual items
-21.56M
-20.17M
-25.94M
-22.25M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-21.56M
-20.17M
-25.94M
-22.25M
Net profit margin
-893.99%
-982.03%
-842.85%
-802.78%
Earnings per share
-0.60
-0.56
-0.72
-0.52
Interest and investment income
3.42M
3.16M
2.79M
3.27M
Interest expense
-201.00K
-149.00K
-92.00K
-39.00K
Net interest expenses
3.22M
3.01M
2.70M
3.23M
Depreciation and amortization charges
-
-
-
-
EBITDA
-24.71M
-23.09M
-28.35M
-25.31M
Gain or loss from assets sale
-
-
23.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer